All news

Algae and plants aren’t called “primary producers” for nothing. They’re the base of all food webs, and the sugars and oxygen they produce through photosynthesis are what allow every other organism on this planet to thrive, including us. So, if they go down, we go down with them.

“The core facilities program at uOttawa — a unique model that is the first of its kind among the U15 — has essentially democratized access to cutting-edge equipment and reliable high-quality research services and expertise,” says Mohamad Nasser-Eddine, associate vice-president, research support and infrastructure, at the University of Ottawa. “Twelve years of investing in our core facilities have ...

With its success in securing multiple prestigious grants, the University of Ottawa is set to further solidify its position as a leading institution in quantum research while breaking new ground in autonomous vehicle technology.

At the pandemic’s outset, uOttawa researcher Michael Organ was approached by Toronto Research Chemicals (TRC) to create a flow reactor that manufactures a key molecule used to prepare PCR test kits to diagnose COVID-19. Billions of tests have since been performed around the world thanks to his flow reactor technology.

That leisurely walk around the block after dinner may do you more good than you thought.

Once again this year, two researchers at early stages in their careers shine bright among uOttawa’s research community. The Office of the Vice-President, Research and Innovation is pleased to present the Early Career Researcher of the Year Award to Erin Maloney, a Faculty of Social Sciences professor who holds the Canada Research Chair in Academic Achievement and Well-Being, and to Peter Tanuseput...

The COVID-19 pandemic led to increased weekday screentime for school-aged children says a new study involving the University of Ottawa published in JAMA Pediatrics.

Physicists and physical chemists from the University of Würzburg and the University of Ottawa have solved a decades-old problem of distinguishing single and multiple light excitations.

More research needed on which patients benefit from seeing a medical specialist before surgery

Researchers have treated the first patient in an innovative clinical trial of a cell therapy that aims to prevent very premature babies from developing a chronic lung disease called bronchopulmonary dysplasia (BPD). This is the first trial of its kind in in the world.